oncogenes for UBC and thus can improve personalized and precision care.
PNO1 was first characterized as a novel RNA-binding gene partner of NOB1 isolated from human kidney. 5 PNO1 is highly conserved, all the way from yeasts up to mammals. 6 In yeasts, PNO1 is reportedly involved in both ribosome and proteasome biogenesis. 7, 8 In mammalian cells, it is localized to the nucleus, especially within the nucleoli. 5 In humans, PNO1 is most abundantly expressed in the thyroid, adrenals, appendix, placenta, bone marrow, urinary bladder and testes (NCBI Gene Database, ID: 56902). Currently, there have been few studies about its functions in mammalian cells, and so far its role in humans has not been reported.
To this end, the aim of the study was to identify the potential involvement of PNO1 in human UBC. The association of PNO1 with UBC was studied both in vitro and in vivo, and its molecular mechanism was predicted through microarray and bioinformatics analysis.
| MATERIAL S AND ME THODS
The human and animal subjects and materials of the paper were approved by the Yantai Yu Huang Ding Hospital's ethical committee.
| Cell culture knockdown of PNO1 by lentivirus
T24 and 5637 bladder cancer cells were routinely cultured in an RPMI-1640 medium (Gibco), supplemented with 10% foetal bovine serum (Gibco) at 37°C in 5% CO 2 humidified incubator. Cells were harvested in a logarithmic phase of growth for all experiments.
Lentivirus carrying the PNO1 gene interfering shRNA sequence (shPNO1, target sequence 5′-TGAACAATTTCAGTCATTT-3′) or non-silencing control (shCtrl, target sequence 5′-TTCTCCGAACGTGTCACGT-3′) was constructed by GeneChem, Shanghai, China. Cells were seeded in plates and grown to a density of 15%-30% in good conditions, before being infected with the above-mentioned lentivirus (containing fluorescence), according to the manufacturer's protocol. The culture medium was changed to normal medium 8-12 hours after infection. Cells were observed 72 hours post-infection with fluorescent microscope to ensure a positive infection rate of >70%.
| RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cells using SuperfecTRI total RNA isolation reagent (Pufei), according to the manufacturer's instructions.
The concentration of RNA was determined by spectrophotometry (Nanodrop 2000/2000C, Thermo Scientific). The total RNA was then reverse-transcribed using M-MLV Reverse Transcriptase (Promega).
qRT-PCR analysis was performed on a LightCycler® 480 System (Roche) with SYBR Master Mixture (DRR041B, TAKARA) according to the manufacturer's protocol. Cycling conditions were as follows:
95°C for 30 seconds, followed by 40 cycles of 95°C for 5 seconds, and then 60°C for 30 seconds. GAPDH was used as endogenous ref- 
| Western blot
Cellular protein extraction and Western blot were performed as previously reported. 9 Proteins were identified with antibodies 
| Automated cell counting
Lentivirus-infected cells were seeded with GFP fluorescence in plates at an appropriate concentration and cultured under routine conditions. Plates were read on a Celigo® Image Cytometer (Nexcelom Bioscience) every day for 5 days, according to the manufacturer's instructions, to obtain the number of fluorescent cells at each time-point. Growth curves based on cell counts or fold changes against the number of cells on day 1 were plotted.
| MTT assay
Cell viability was analysed using an MTT assay. Two thousand cells
were seeded in each well of the 96-well plates and cultured under routine conditions. At each time-point, 20 μL of 5 mg/mL MTT (Genview) was added to each well, followed by a 4-hour incubation after which the culture medium was replaced by 100 μL DMSO.
Following 2-5 minutes agitation, the optical densities at 490 nm wavelength (OD490) were measured on an Infinite® M2009PR microplate reader (Tecan). Growth curves based on OD490 or fold changes against the OD490 on day 1 were plotted.
| Colony formation assay
Cells infected with lentivirus for 3 days were seeded in 6-well plates at a concentration of 800 per well and cultured for around 10 days. Cells in each well were fixed with 1 mL 4% paraformaldehyde for 30-60 minutes and stained with 500 μL GIEMSA Stain (Sigma-Aldrich) for 10-20 minutes. Following several washes by ddH 2 O, images were taken and colony numbers were counted. 
| Cell apoptosis assay

| DNA microarray and bioinformatics analysis
Total RNA extracted from T24 cells expressing shCtrl or shPNO1
was analysed with the Agilent 2100 Bioanalyzer system (Agilent) and used for preparing amplified RNA (aRNA) with the GeneChip® 3′IVT 
| Antibody microarray
Antibody 
| Statistical analysis
Statistical analysis was performed using the GraphPad Prism 7.0 software. The results were expressed as mean ± standard deviation.
The data were analysed initially by F test to check the equality of variances. Data with F-value < 0.05 were subjected to two-tailed
Welch's t test, and those with F-value > 0.05 were subjected to twotailed Student's t test. P < .05 in the t test suggested statistically significant difference.
| RE SULTS
| Clinicopathological factors associated with PNO1 expression in bladder cancer tissues
We first evaluated PNO1 expression in 56 bladder urothelial carcino- 
| Role of PNO1 in growth and survival of bladder cancer cells
We studied the role of PNO1 in two bladder cancer cell lines, T24 and KD cells (shPNO1) was significantly attenuated in both cell lines. It was also confirmed that for both cell lines in the KD group, the colonogenesis ability was significantly attenuated (P < .001), while cell apoptosis was significantly activated (P < .001; Figure 2G ,H). These results indicated that PNO1 was important for the proliferation and survival of bladder cancer cells.
| Attenuation tumour growth in vivo after PNO1 knockdown
To study the function of PNO1 in bladder cancer in vivo used the Figure 4A ,B. RNA microarray data were subjected to IPA analysis.
| Canonical pathway analysis
Sixteen significantly altered canonical signalling and metabolic pathways correlated with DEGs (−log P > 1.3 and |Z-score| > 2) and were summarized by IPA ( Figure 4C , Table 1 ). The Acute-phase response signalling pathway was the most significantly enriched and down-regulated pathway involving the identified DEGs (−log P = 4.54), whose signalling was the only up-regulated pathway.
| Upstream regulation analysis
The upstream regulating genes of DEGs were analysed. One hundred and fifty-eight genes were predicted to significantly 
| Disease and function analysis
The inhibition or activation of diseases and physiological functions by up-or down-regulated DEGs was analysed and plotted in 
| Regulator effect analysis
The possible routes of DEGs participating in the upstream regula- 
CYR61, EGFR, EGR1, F3, IL1B, IL6, KLF5, PLAU, PLAUR, PTGS2, S1PR3,
SERPINE1, TNF and WNT5A with the highest consistency score ( Figure S4 ).
| Interaction network among DEGs
The interaction networks among all DEGs were also analysed, and results showed that the top diseases and functions significantly correlated with interacting molecules within the network were as follows:
haematological disease, hereditary disorder, organismal injury and abnormalities, which involved 34 DEGs ( Table 2 ). The interaction of molecules within the top-scored network was presented in Figure 4E .
| PNO1-regulated gene expression
Based on the above informatics analysis, we chose PNO1 and some
of its downstream genes (CD44, PTGS2, CCND1, CDK1, F3, CXCL8
and FOSL1) for interaction analysis, and the gene interaction network is shown in Figure 5A . The protein expression of these genes was further confirmed by Western blot in T24NC and T24KD cells ( Figure 5B ). Apart from F3, the expression of all genes was significantly reduced as a result of PNO1 knockdown, which was consistent with the microarray result.
In addition, the effect of PNO1 on 18 key node proteins of intracellular signalling pathways that are closely associated with diseases was studied by antibody array. Results showed that, among these proteins, mTOR, p70 S6 kinase, p38 and Caspase-3 were significantly down-regulated in PNO1 KD cells ( Figure 5C ).
| D ISCUSS I ON
Previously PNO1 was well known as a RNA-binding protein in humans, and its ortholog PNO1 was reported to participate in ribosome and proteasome biogenesis in yeasts. Wang had generated Note: −log(P-value) > 1.3, which meant P < .05, represented significant correlation between DEGs and the pathway. Z-score > 2 suggested significant activation of the pathway while Z-score < −2 suggested significant repression of the pathway.
TA B L E 1
List of significantly up-or down-regulated regulated canonical pathways that were significantly related to differentially expressed genes (DEGs) between NC and PNO1 KD T24 cells tumour cells were also down-regulated in PNO1 KD cells, indicating that PNO1 might also participate in the metastasis of cancer cells.
IPA analysis retrieved 16 significantly altered canonical pathways from the DEGs, among which the PPAR signalling was the only up-regulated pathway after KD of PNO1. As one of the three peroxisome proliferator-activated receptors, PPARγ is a ligand-activated transcription factor of the nuclear hormone receptor superfamily, which have a contradictory role on tumorigenicity, in addition to its role in glucose and lipid metabolism and inflammation. 10 A number of PPARγ ligands were reported to bear a potential of increased risk of UBC. 11, 12 Previous study suggested that loss of PPARγ may be an important step in the progression of UBC. 13 The natural ligand of PPARγ, 15d-PGJ(2), could inhibit the proliferation and induce the apoptosis of T24 and 5637 cells, through induction of the production of reactive oxygen species (ROS). 14 However, another study reported dramatically increased amplification of PPARγ in UBC tissues, especially those with lymph node metastasis and that PPARγ played an important role in 5673 cell migration and invasion. 15 This controversy in PPARγ function reflected the complexity of PPAR signal modulating mechanism in UBC. The acute-phase response was the most significantly enriched down-regulated pathway involving the identified DEGs, which is characterized by alteration in the concentrations of a number of plasma proteins produced by the liver, in response to cytokines including IL-1, IL-6, IL-8, TNFα, etc during inflammatory response.
16
The acute-phase proteins (APPs), C-reactive protein (CRP) and orosomucoid (ORM) were reported to be important prognostic or diagnostic biomarkers for UBC. 17, 18 Comparing the identified activation/inhibition status of proteins in the acute-phase response signalling based on our test result ( Figure S1 ) and that reported by TA B L E 2 List of interaction networks among DEGs ranked according to the significance level, which reflected the number of DEGs included CD44 antigen is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and cell migration. It is stimulated by IL-6 and was implicated with higher clinical stage, radio-resistance, cancer stem cell-like property and resistance to apoptosis in UBC. [19] [20] [21] Prostaglandin-endoperoxide synthase 2 (PTGS2) is also known as cyclooxygenase-2 (COX-2), 22 which was one of the two isoforms of cyclooxygenases. Cyclooxygenases catalyse the initial step in the formation of prostaglandins (PGs), which are involved in various inflammatory cell processes including carcinogenesis. As PTGS1 was predominantly expressed in urothelium while UBC cells exhibited PTGS2 overexpression, 23 the transition between PTGS isoforms might contribute to the tumorigenesis of UBC. PTGS2 activation might also be involved in inflammation-mediated cancer stem cell proliferation during bladder carcinogenesis. 24 Cyclin D1 (CCND1) is involved in regulating the cell cycle progression and growth factor signalling, making it a possible oncogene. One of its two isoforms, cyclin D1b is important for the malignant phenotypes of human UBC cells via suppression of apoptosis, induction of cancer cell stemness and epithelial-mesenchymal transition. 25 Altered expression of cyclin D1 was reported to be associated with lymph node metastasis and risk of recurrence of UBC. 26 As a binding partner of cyclins, cyclin-dependent kinase 1 (CDK1) is also a key player in cell cycle regu- This study also revealed a down-regulation of mTOR, p70 S6 kinase, p38 and caspase-3 proteins in PNO1 KD cells, suggesting the association of PNO1 with several intracellular signalling pathways.
mTOR and p70 S6 kinase are both key components of the mTOR signalling pathway, which promotes cell growth and proliferation in eukaryotic cells. 28 Altered mTOR pathway activity has been noted in a variety of human tumours, including urothelial carcinoma. 29 mTOR pathway activation was reported to be involved in UBC tumorigenesis and was a predictor of cancer progression and poor survival.
30
p38 mitogen-activated protein kinases belong to the MAPK family and are activated by stress stimuli, such as cytokines, ultraviolet irradiation, heat shock and osmotic shock. The activation of p38
MAPKs has been reported to contribute to the epithelial-mesenchymal transition of cells in the primary tumour, to the acquisition of invasion and migrating capabilities and to the extravasation of migrating tumour cells, while p38 MAPK inhibition has been correlated with the resistance to anoikis. 31 Caspase-3 belongs to the caspase family and plays an indispensable role in the execution-phase of cell apoptosis. 32 However, the significantly increased apoptotic activity in T24KD cells that was observed contradicted the down-regulation of caspase-3. We suspected that this might be caused by experimental errors.
This is the first time the cellular functions and clinical significance of PNO1 in UBC was investigated, and its molecular mechanism explored through microarrays and bioinformatics analysis. Our 
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